Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Brod, Meryl ^a   Hammer, Mette ^b   Kragh, Nana ^b   Lessard, Suzanne ^a   Bushnell, Donald M ^c  

^a Brod Group   (United States)

^b NOVO NORDISK A S   (Denmark)

^c Health Research Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEPRAMONE; ANTIOBESITY AGENT; PHENDIMETRAZINE; PHENTERMINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ASSESSMENT TOOL; COGNITION; FEMALE; HEALTH SURVEY; HUMAN; INCOME; INTERNAL CONSISTENCY; LIFE EVENT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PRESCRIPTION; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; STATISTICAL ANALYSIS; TREATMENT RELATED IMPACT MEASURE WEIGHT; VALIDATION STUDY; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY;

ANTI-OBESITY AGENTS; BODY WEIGHT; HUMANS; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 77950400449     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-19     Document Type: Article

References (42)

1. Ballantyne GH. Measuring outcomes following bariatric surgery: weight loss parameters, improvement in co-morbid conditions, change in quality of life and patient satisfaction. Obes Surg 2003, 13:954-964. 10.1381/096089203322618867, 14738691.
2. Foster GD, Wadden TA, Phelan S, Sarwer DB, Sanderson RS. Obese patients' perceptions of treatment outcomes and the factors that influence them. Arch Intern Med 2001, 161:2133-2139. 10.1001/archinte.161.17.2133, 11570944.
3. Albrecht G, Hoogstraten J. Satisfaction as determination of compliance. Community Dent Oral Epidemiol 1998, 26:139-146. 10.1111/j.1600-0528.1998.tb01940.x, 9645408.
4. Digenio AG, Mancuso JP, Gerber RA, Dvorak RV. Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. Ann Intern Med 2009, 150:255-262.
5. Levy LD, Fleming JP, Klar D. Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder. Int J Obes 2009, 33:326-334.
6. Anderson R, Marrero D, Skovlund SE, Cramer J, Schwartz S. Self-reported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes. Diabetologia 2003, 46:A275.
7. Brody DS, Miller SM, Lerman CE, Smith DG, Caputo GC. Patient perception of involvement in medical care: relationship to illness attitudes and outcomes. J Gen Intern Med 1989, 4:506-511. 10.1007/BF02599549, 2585158.
8. McCracken LM, Klock PA, Mingay DJ, Asbury JK, Sinclair DM. Assessment of satisfaction with treatment for chronic pain. J Pain Symptom Manage 1997, 14:292-299. 10.1016/S0885-3924(97)00225-X, 9392923.
9. Cappelleri JC, Gerber RA, Kourides IA, Gelfand RA. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care 2000, 23:1799-1803. 10.2337/diacare.23.12.1799, 11128356.
10. Anderson RT, Skovlund SE, Marrero D, Levine DW, Meadows K, Brod M, Balkrishnan R. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther 2004, 26:565-578. 10.1016/S0149-2918(04)90059-8, 15189754.
11. Colman SS, Brod MI, Krishnamurthy A, Rowland CR, Jirgens KJ, Gomez-Mancilla B. Treatment satisfaction, functional status and health related quality of life of patients with migraine randomly assigned to almotriptan or sumatriptan. Clin Ther 2001, 23:127-145.12. 10.1016/S0149-2918(01)80036-9, 11219473.
12. Brod M, Hammer M, Lessard S, Kragh N. Understanding and Assessing the Impact of Prescription Weight Loss Medication: Conceptual, Gender, and Cultural Issues [abstract]. Value Health 2008, 11:A642-643.
13. Drew BS, Dixon AF, Dixon JB. Obesity management: update on orlistat. Vasc Health Risk Manag 2007, 3:817-821. 2350121, 18200802.
14. Ersoz HO, Ukinc K, Baykan M, Erem C, Durmus I, Hacihasanoglu A, Telatar M. Effect of low-dose matoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study. Int J Obes 2004, 28:378-383.
15. Brod M, Hammer M, Lessard S, Kragh N. Understanding and assessing the impact of prescription weight loss medication: Conceptual, gender and cultural issues. Value in Health 2008, 11:642.
16. U.S. Food and Drug Administration (USFDA) Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labelling Claims: Draft Guidance. 2006, U.S. Food and Drug Administration (USFDA)., http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071975.pdf
17. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measur 1977, 1:385-401.
18. Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a new measure for evaluating somatic symptom severity. Psychosom Med 2002, 64:258-266.
19. Van Ravesteijn H, Wittkampf K, Lucassen P, Lisdonk E, Hoogen H, Van Weert H, Huijsser J, Schene A, Van Weel C, Speckens A. Detecting Somatoform Disorders in Primary Care with the PHQ-15. Ann FamMed 2009, 7:232-238.
20. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233. 10.1097/00005650-199603000-00003, 8628042.
21. Gandek B, Ware JE, Aaronson NK, Appolone G, Bjorner JB, Brazie JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries: Results from the IQOLA Project. J Clin Epidemiol 1998, 51:1171-1178. 10.1016/S0895-4356(98)00109-7, 9817135.
22. Cheak-Zamora NC, Wyrwich KW, McBride TD. Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Qual Life Res 2009, 18:727-735. 10.1007/s11136-009-9483-1, 19424821.
23. Wild DJ, Clayson DJ, Keating K, Gondek K. Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the Activity Impairment Assessment (AIA). Health Qual Life Outcomes 2005, 3:42. 10.1186/1477-7525-3-42, 1180845, 16022727.
24. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004, 2:12. 10.1186/1477-7525-2-12, 398419, 14987333.
25. Bharmal M, Payne K, Atkinson MJ, Desrosiers M, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes 2009, 7:36-46. 10.1186/1477-7525-7-36, 2678998, 19397800.
26. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract 2006, 12:71-79. 10.1097/00131746-200603000-00002, 16728903.
27. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacology Bulletin 1993, 29:321-326.
28. Schechter D, Endicott J, Nee J. Quality of life of 'normal' controls: Association with lifetime history of mental illness. Psychiatry Res 2007, 152:45-54. 10.1016/j.psychres.2006.09.008, 2291021, 17363070.
29. Brod M, Hammer M, Christensen T, Lessard S, Bushnell DM. Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device). Health Qual Life Outcomes 2009, 7:83. 10.1186/1477-7525-7-83, 2758841, 19740444.
30. SPSS Inc SPSS for Windows, Rel. 11.5.0 2002, Chicago: SPSS Inc, SPSS Inc.
31. Scientific Advisory Committee of the Medical Outcomes Trust Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002, 11:193-205. 10.1023/A:1015291021312, 12074258, Scientific Advisory Committee of the Medical Outcomes Trust.
32. Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychopharmacol Bull 1959, 56:81-105.
33. Bentler PM. Comparative fit indices in structural models. Psychol Bull 1990, 107:238-246. 10.1037/0033-2909.107.2.238, 2320703.
34. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16:297-334.
35. Niero M, Martin M, Finger T, Lucas R, Mear I, Wild D, Glauda L, Patrick DL. A new approach to multicultural item generation in the development of two obesity-specific measures: the Obesity and Weight Loss Quality of Life (OWLQOL) Questionnaire and the Weight-Related Symptom Measure (WRSM). Clin Ther 2002, 24:690-700. 10.1016/S0149-2918(02)85144-X, 12017412.
36. Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002, 184:51S-54S. 10.1016/S0002-9610(02)01181-9, 12527352.
37. Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. Obes Rev 2001, 2:219-229. 10.1046/j.1467-789X.2001.00040.x, 12119993.
38. Kushner R, Foster GD. Obesity and quality of life. Nutrition 2000, 16:947-952. 10.1016/S0899-9007(00)00404-4, 11054600.
39. Miller-Kovach K, Hermann M, Winick M. The psychological ramifications of weight management. J Womens Health Gend Based Med 1999, 8:477-482.
40. Kleinman L, Leidy N, Crawley J, Bonomi A, Schoenfeld P. A comparative trial of paper-and-pencil versus computer administration of the Quality of Life in Reflux and Dyspepsia (QOLRAD) Questionnaire. Med Care 2001, 39:181-189. 10.1097/00005650-200102000-00008, 11176555.
41. Bushnell DM, Martin M, Parasuraman B. Electronic versus paper questionnaires: A further comparison in persons with asthma. The Journal of Asthma 2003, 40:751-762. 10.1081/JAS-120023501, 14626331.
42. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: A meta-analytic review. Value in Health 2008, 11:322-33. 10.1111/j.1524-4733.2007.00231.x, 18380645.